54.78MMarket Cap
LossP/E TTM
Dogwood Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Dogwood Therapeutics Inc is 6.66, ranking 270 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.23, which is -132.19% below the recent high of 0.07 and -2892.47% above the recent low of -6.88.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.